bioSyntagma

Eliminating trial-and-error cancer treatments through biomarker discovery and predictive analytics

General Information
Company Name
bioSyntagma
Founded Year
2015
Location (Offices)
Phoenix, United States +2
Founders / Decision Makers
Number of Employees
2
Industries
Biotechnology, Life Sciences
Funding Stage
Grant
Social Media

bioSyntagma - Company Profile

bioSyntagma is a precision medicine company dedicated to transforming how cancer is treated by providing deep data on the uniqueness of each person’s cancer. The company’s Molecular Fingerprint™ (mPrint™) platform creates a comprehensive, multi-omic and spatial profile of tissue to get a complete and informed understanding of the patient’s cancer so they can be matched with relevant therapies and recommended course of actions that prevent acquired drug resistance. bioSyntagma’s mPrint™ platform serves the needs of clinicians, academic researchers, and drug developers to advance the implementation of precision medicine for cancer treatment.

Funding Rounds & Investors of bioSyntagma (4)

View All
Funding Stage Amount No. Investors Investors Date
Grant $196.00K 1 National Institutes of Health 19 Mar 2018
Grant $892.09K 1 06 Feb 2018
Grant $214.00K 1 01 Jan 2017
Grant $80.00K - 05 Oct 2016

Latest News of bioSyntagma

View All

No recent news or press coverage available for bioSyntagma.

Similar Companies to bioSyntagma

View All
BostonGene - Similar company to bioSyntagma
BostonGene Transforming Cancer Care: From Treating a Diagnosis to Treating the Person
BIOMAKERS - Similar company to bioSyntagma
BIOMAKERS Empowering Therapies with Precision Data
Tailor Bio - Similar company to bioSyntagma
Tailor Bio Pan-cancer precision medicine platform.
Asylia Diagnostics BV - Similar company to bioSyntagma
Asylia Diagnostics BV Diagnostics technology platform intended to provide safer immunotherapy for cancer patients
Akiram Therapeutics - Similar company to bioSyntagma
Akiram Therapeutics Advancing radiotherapeutics to treat solid tumors